{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T23:34:55Z","timestamp":1770507295107,"version":"3.49.0"},"reference-count":36,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2015,5,29]],"date-time":"2015-05-29T00:00:00Z","timestamp":1432857600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0126891","type":"journal-article","created":{"date-parts":[[2015,5,29]],"date-time":"2015-05-29T18:27:05Z","timestamp":1432924025000},"page":"e0126891","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":41,"title":["Targeting KRAS Oncogene in Colon Cancer Cells with 7-Carboxylate Indolo[3,2-b]quinoline Tri-Alkylamine Derivatives"],"prefix":"10.1371","volume":"10","author":[{"given":"Hugo","family":"Brito","sequence":"first","affiliation":[]},{"given":"Ana Cl\u00e1udia","family":"Martins","sequence":"additional","affiliation":[]},{"given":"Jo\u00e3o","family":"Lavrado","sequence":"additional","affiliation":[]},{"given":"Eduarda","family":"Mendes","sequence":"additional","affiliation":[]},{"given":"Ana Paula","family":"Francisco","sequence":"additional","affiliation":[]},{"given":"Sofia A.","family":"Santos","sequence":"additional","affiliation":[]},{"given":"Stephan A.","family":"Ohnmacht","sequence":"additional","affiliation":[]},{"given":"Nam-Soon","family":"Kim","sequence":"additional","affiliation":[]},{"given":"Cec\u00edlia M. P.","family":"Rodrigues","sequence":"additional","affiliation":[]},{"given":"Rui","family":"Moreira","sequence":"additional","affiliation":[]},{"given":"Stephen","family":"Neidle","sequence":"additional","affiliation":[]},{"given":"Pedro M.","family":"Borralho","sequence":"additional","affiliation":[]},{"given":"Alexandra","family":"Paulo","sequence":"additional","affiliation":[]}],"member":"340","published-online":{"date-parts":[[2015,5,29]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/onc.2010.430","article-title":"Dasatinib sensitizes KRAS mutant colorectal tumors to cetuximab","volume":"30","author":"EF Dunn","year":"2011","journal-title":"Oncogene"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.drudis.2010.05.012","article-title":"Therapeutic modulation of k-ras signaling in colorectal cancer","volume":"15","author":"LL Krens","year":"2010","journal-title":"Drug Discovery Today"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"J Ferlay","year":"2015","journal-title":"Int J Cancer"},{"issue":"Suppl 1","key":"ref4","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1159\/000086183","article-title":"Mechanisms of drug resistance in cancer chemotherapy","volume":"14","author":"YA Luqmani","year":"2005","journal-title":"Med Princ Pract"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/nrd4389","article-title":"Drugging the undruggable RAS: Mission Possible?","volume":"13","author":"AD Cox","year":"2014","journal-title":"Nat Rev Drug Discov"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1159\/000334678","article-title":"Search for Novel Target Molecules for the Effective Treatment or Prevention of Colorectal Cancer","volume":"85","author":"M Tsujii","year":"2012","journal-title":"Digestion"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"6689","DOI":"10.1111\/j.1742-4658.2009.07383.x","article-title":"MicroRNA-143 reduces viability and increases sensitivity to 5-fluorouracil in HCT116 human colorectal cancer cells","volume":"276","author":"PM Borralho","year":"2009","journal-title":"Febs J"},{"issue":"8","key":"ref8","doi-asserted-by":"crossref","first-page":"e23787","DOI":"10.1371\/journal.pone.0023787","article-title":"miR-143 Overexpression Impairs Growth of Human Colon Carcinoma Xenografts in Mice with Induction of Apoptosis and Inhibition of Proliferation","volume":"6","author":"PM Borralho","year":"2011","journal-title":"Plos One"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"6903","DOI":"10.1016\/j.bmcl.2012.09.029","article-title":"Development of triazene prodrugs for ADEPT strategy: New insights into drug delivery system based on carboxypeptidase G2 activation","volume":"22","author":"V Capucha","year":"2012","journal-title":"Bioorg Med Chem Lett"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2013.09.040","article-title":"Synthesis and evaluation of N-acylamino acids derivatives of triazenes. Activation by tyrosinase in human melanoma cell lines","volume":"70","author":"AS Monteiro","year":"2013","journal-title":"Eur J Med Chem"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"3228","DOI":"10.1016\/j.ejmech.2009.03.025","article-title":"Dopamine- and tyramine-based derivatives of triazenes: Activation by tyrosinase and implications for prodrug design","volume":"44","author":"MJ Perry","year":"2009","journal-title":"Eur J Med Chem"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1093\/nar\/gkl286","article-title":"G-quadruplex formation within the promoter of the KRAS proto-oncogene and its effect on transcription","volume":"34","author":"S Cogoi","year":"2006","journal-title":"Nucleic Acids Res"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"3765","DOI":"10.1093\/nar\/gkn120","article-title":"Structural polymorphism within a regulatory element of the human KRAS promoter: formation of G4-DNA recognized by nuclear proteins","volume":"36","author":"S Cogoi","year":"2008","journal-title":"Nucleic Acids Res"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"5402","DOI":"10.1093\/nar\/gkl655","article-title":"Quadruplex DNA: sequence, topology and structure","volume":"34","author":"S Burge","year":"2006","journal-title":"Nucleic Acids Res"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1111\/j.1742-4658.2009.07463.x","article-title":"Human telomeric G-quadruplex: The current status of telomeric G-quadruplexes as therapeutic targets in human cancer","volume":"277","author":"S Neidle","year":"2010","journal-title":"Febs J"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrd3428","article-title":"Targeting G-quadruplexes in gene promoters: a novel anticancer strategy?","volume":"10","author":"S Balasubramanian","year":"2011","journal-title":"Nat Rev Drug Discov"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1016\/j.bmcl.2014.04.029","article-title":"Small-molecule quadruplex-targeted drug discovery","volume":"24","author":"SA Ohnmacht","year":"2014","journal-title":"Bioorg Med Chem Lett"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"5867","DOI":"10.1039\/c1cs15067g","article-title":"The application of DNA and RNA G-quadruplexes to therapeutic medicines","volume":"40","author":"GW Collie","year":"2011","journal-title":"Chem Soc Rev"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1039\/C1CC15850C","article-title":"Photoactivated cationic alkyl-substituted porphyrin binding to g4-RNA in the 5 &apos;-UTR of KRAS oncogene represses translation","volume":"48","author":"M Faudale","year":"2012","journal-title":"Chem Commun"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"4727","DOI":"10.1093\/nar\/gks068","article-title":"5&apos;-UTR RNA G-quadruplexes: translation regulation and targeting","volume":"40","author":"A Bugaut","year":"2012","journal-title":"Nucleic Acids Res"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"7042","DOI":"10.1016\/j.bmcl.2010.09.110","article-title":"C-11 diamino cryptolepine derivatives NSC748392, NSC748393 and NSC748394: Anticancer profile and G-quadruplex stabilization","volume":"20","author":"J Lavrado","year":"2010","journal-title":"Bioorg Med Chem Lett"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.2174\/092986710791698521","article-title":"Indoloquinolines as Scaffolds for Drug Discovery","volume":"17","author":"J Lavrado","year":"2010","journal-title":"Curr Med Chem"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1016\/S0960-894X(00)00378-4","article-title":"A novel inhibitor of human telomerase derived from 10<italic>H<\/italic>-indolo[3,2-<italic>b<\/italic>]quinoline","volume":"10","author":"V Caprio","year":"2000","journal-title":"Bioorg Med Chem Lett"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1021\/jm0610088","article-title":"Stabilization of G-quadruplex DNA and down-regulation of oncogene c-myc by quindoline derivatives","volume":"50","author":"TM Ou","year":"2007","journal-title":"J Med Chem"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1002\/cmdc.201300288","article-title":"Synthesis, G-Quadruplex Stabilisation, Docking Studies, and Effect on Cancer Cells of Indolo[3,2-<italic>b<\/italic>]quinolines with One, Two, or Three Basic Side Chains","volume":"8","author":"J Lavrado","year":"2013","journal-title":"Chemmedchem"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"4965","DOI":"10.1039\/c1cc10269a","article-title":"Primer extension reactions as a tool to uncover folding motifs within complex G-rich sequences: analysis of the human KRAS NHE","volume":"47","author":"M Paramasivam","year":"2011","journal-title":"Chem Commun (Camb)"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"5930","DOI":"10.1016\/j.bmcl.2012.07.065","article-title":"Sequences in the HSP90 promoter form G-quadruplex structures with selectivity for disubstituted phenyl bis-oxazole derivatives","volume":"22","author":"SA Ohnmacht","year":"2012","journal-title":"Bioorg Med Chem Lett"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1021\/jm050555a","article-title":"Trisubstituted acridines as G-quadruplex telomere targeting agents. Effects of extensions of the 3,6-and 9-side chains on quadruplex binding, telomerase activity, and cell proliferation","volume":"49","author":"MJB Moore","year":"2006","journal-title":"J Med Chem"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1021\/ja2102423","article-title":"Structural Basis for Telomeric G-Quadruplex Targeting by Naphthalene Diimide Ligands","volume":"134","author":"GW Collie","year":"2012","journal-title":"JACS"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/sj.onc.1209813","article-title":"Targeting inhibition of K-ras enhances Ad.mda-7-induced growth suppression and apoptosis in mutant K-ras colorectal cancer cells","volume":"26","author":"IV Lebedeva","year":"2007","journal-title":"Oncogene"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"4049","DOI":"10.1093\/nar\/gkt127","article-title":"MAZ-binding G4-decoy with locked nucleic acid and twisted intercalating nucleic acid modifications suppresses KRAS in pancreatic cancer cells and delays tumor growth in mice","volume":"41","author":"S Cogoi","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"3792","DOI":"10.1093\/nar\/gkt1354","article-title":"G-Quadruplex binding enantiomers show chiral selective interactions with human telomere","volume":"42","author":"JS Wang","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"a001883","DOI":"10.1101\/cshperspect.a001883","article-title":"Tumor suppressive functions of p53","volume":"1","author":"JT Zilfou","year":"2009","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.bbadis.2006.09.005","article-title":"Inhibition of Fas expression by RNAi modulates 5-fluorouracil-induced apoptosis in HCT116 cells expressing wild-type p53","volume":"1772","author":"PM Borralho","year":"2007","journal-title":"Biochim Biophys Acta"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"12888","DOI":"10.1039\/c2dt11577h","article-title":"Cobalt complexes bearing scorpionate ligands: synthesis, characterization, cytotoxicity and DNA cleavage","volume":"41","author":"TF Silva","year":"2012","journal-title":"Dalton Trans"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.jep.2013.06.051","article-title":"Monoterpene bisindole alkaloids, from the African medicinal plant Tabernaemontana elegans, induce apoptosis in HCT116 human colon carcinoma cells","volume":"149","author":"TA Mansoor","year":"2013","journal-title":"J Ethnopharmacol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0126891","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,9]],"date-time":"2024-06-09T08:11:41Z","timestamp":1717920701000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0126891"}},"subtitle":[],"editor":[{"given":"A R M Ruhul","family":"Amin","sequence":"first","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2015,5,29]]},"references-count":36,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2015,5,29]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0126891","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,29]]}}}